Ironwood Pharmaceuticals Inc (IRWD) support and resistance · P/E 5.7, rev $219.5M
Ironwood Pharmaceuticals Inc (IRWD) is a drug manufacturers - specialty & generic company listed on NASDAQ.
This page maps Ironwood Pharmaceuticals Inc (IRWD) support and resistance from cached range and valuation — not a live tape and not a trade alert.
Latest reported IRWD revenue for 2026-06-30 was $219.5M. Net income was $92.1M. IRWD currently screens at market cap $579.4M and trailing P/E 5.7.
IRWD currently screens at market cap $579.4M and trailing P/E 5.7. Round numbers near that cap and multiple often act as psychological resistance; prior-period revenue is the fundamental floor traders argue about.
A new IRWD 8-K or 10-Q can move the levels that matter more than a drawing on a chart.
Not investment advice. Use the IRWD quote page for the session range and the stock page for the full model.
Not investment advice.